Chris Xu | Chairman and CEO |
Jeff Cauble | Principal Accounting Officer |
Paula Schwartz | IR, Rx Communications |
Sean Lee | H.C. Wainwright |
Good day, everyone, and welcome to the Cesca Therapeutics Conference Call and Webcast to review Financial and Operating Results for the Third Quarter ended September 30, 2018.
As a reminder, all participants are in a listen-only mode. There will be an opportunity for you to ask questions at the end of today's presentation. [Operator Instructions]. Today’s conference call is being recorded.